A projection framing weight loss drugs as a growing slice of American healthcare spending. Thin on detail beyond the market forecast.
Recap by typeshit. Post by WalletHub on X.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Featured in Everyday Health, the NYITCOM doctor shares guidance on common mistakes people make with the new oral GLP-1 medications.
Investor Steve Wagner says he is uneasy about Novo's Q3, pointing to a Medicare price cut on Ozempic, still its top revenue driver, that began around July 1.
Loading…